Search results for "Cancer"

showing 10 items of 11546 documents

Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density.

2009

Polymorphisms of the sex hormone-binding globulin (SHBG) gene are associated with differences in SHBG levels, influencing the risk for breast cancer and polycystic ovarian syndrome, but no association has been reported for osteoporosis in postmenopausal women.To determine the effect of G to A substitution in the 5'UTR (rs1799941) and the Asp356Asn (rs6259) polymorphisms of the SHBG gene on bone mineral density (BMD).This is a cross-sectional study in a university-based research center from May, 2002 to December, 2007. A total of two hundred and thirteen healthy postmenopausal Caucasian womenor = 1 year from last menstrual period participated to this study. Serum estradiol by ultrasensitive …

medicine.medical_specialtyHistologyBone densityGlobulinGenotypePhysiologyEndocrinology Diabetes and MetabolismOsteoporosisBiologyPolymorphism Single NucleotideArticleBreast cancerSex hormone-binding globulinBone DensityInternal medicineSex Hormone-Binding GlobulinGenotypemedicineHumansBone mineralImmunoradiometric assayEstradiolMiddle Agedmedicine.diseaseEndocrinologybiology.proteinFemale5' Untranslated RegionsBone
researchProduct

Diagnosis of Lung Cancer Due to a Complicated Abscess

2019

medicine.medical_specialtyHistologybusiness.industryRadiographyMEDLINEDermatologymedicine.diseasePathology and Forensic MedicineAxillamedicine.anatomical_structuremedicineRadiologybusinessAbscessLung cancerActas Dermo-Sifiliográficas (English Edition)
researchProduct

Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and…

2019

Although the arrival of new chemotherapy drugs and combinations has brought progress in terms of cancer patient survival, they entail many adverse effects that can compromise treatment, and hence prognosis, of the disease. Cytostatic agents can cause dermatological toxicity, among other side effects. The most familiar adverse effect of chemotherapy is alopecia. Although not serious, this changes the outward appearance of cancer patients. Other adverse effects include hypersensitivity and photosensitivity reactions, hand-foot syndrome, epidermal necrolysis, recall reactions, scleroderma-like reactions, Raynaud's phenomenon, eccrine squamous syringometaplasia, neutrophilic eccrine hidradeniti…

medicine.medical_specialtyHistologymedicine.medical_treatmentNeutrophilic eccrine hidradenitisDermatologyDiseasePathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifePhotosensitivityHyperpigmentationRashChemotherapyMedicineskin and connective tissue diseasesAdverse effectChemotherapybusiness.industryDermatological toxicityCancermedicine.diseaseDermatologyHyperpigmentationRash030220 oncology & carcinogenesismedicine.symptomCutaneous toxicitybusinessActas Dermo-Sifiliográficas (English Edition)
researchProduct

8 A multicentric randomized trial to evaluate the role of uterine manipulator on laparoscopic/robotic hysterectomy for the treatment of low-risk endo…

2020

Background The role of the intrauterine manipulator in minimally invasive hysterectomy for endometrial cancer has been widely debated in terms of impact on the oncological outcomes. To date, definitive conclusions on the possible advantages and oncological safety of its use in endometrial cancer staging are still awaited. Objectives This randomized trial aimed to assess the role of the uterine manipulator in terms of oncological and perioperative outcomes in patients undergoing minimally invasive (laparoscopic/robotic) staging for presumed low-risk endometrial cancer. Study Design Enrolled patients were randomly allocated in two groups according to the use (Group A) or no use (Group B) of t…

medicine.medical_specialtyHysterectomybusiness.industrymedicine.medical_treatmentEndometrial cancerPerioperativemedicine.diseaseGroup BUterine manipulatorlaw.inventionSurgeryRobotic hysterectomyRandomized controlled triallawLaparotomymedicinebusinessOral Plenary
researchProduct

Multiparametric 18F-FDG PET-MRI of the breast: are there differences in imaging biomarkers of contralateral healthy tissue between patients with and …

2019

The rationale was to assess whether there are differences in multiparametric 18F-FDG PET/MRI biomarkers of contralateral healthy breast tissue in patients with benign and malignant breast tumors. Methods: In this institutional review board-approved prospective single-institution study, 141 women with imaging abnormalities on mammography or sonography (BI-RADS 4/5) underwent combined 18F-FDG PET/MRI of the breast at 3T with dynamic contrast-enhanced MRI, diffusion-weighted imaging, and the radiotracer 18F-FDG. In all patients, the following imaging biomarkers were recorded for the contralateral (tumor-free) breast: breast parenchymal uptake (BPU) (from 18F-FDG PET), mean apparent diffusion c…

medicine.medical_specialtyImaging biomarkerdiffusion-weighted imagingMalignancy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerF-18-FDG PET/MRImedicineMammographyEffective diffusion coefficientF-18-FDG PET/MRI breast cancer; dynamic contrast-enhanced MRI diffusion-weighted imaging imaging biomarkerimaging biomarkerRadiology Nuclear Medicine and imagingdynamic contrast-enhanced MRImedicine.diagnostic_testbusiness.industryCancermedicine.disease030220 oncology & carcinogenesisDynamic contrast-enhanced MRIRadiologybusinessDiffusion MRI
researchProduct

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study.

2020

Abstract Patients with Philadelphia-negative myeloproliferative neoplasm (MPN) are prone to the development of second cancers, but the factors associated with these events have been poorly explored. In an international nested case-control study, we recruited 647 patients with carcinoma, nonmelanoma skin cancer, hematological second cancer, and melanoma diagnosed concurrently or after MPN diagnosis. Up to 3 control patients without a history of cancer and matched with each case for center, sex, age at MPN diagnosis, date of diagnosis, and MPN disease duration were included (n = 1234). Cases were comparable to controls for MPN type, driver mutations and cardiovascular risk factors. The freque…

medicine.medical_specialtyImmunologyKaplan-Meier EstimateGene mutationBiochemistryGastroenterologyMyeloproliferative neoplasms03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingInternal medicineCarcinomaMedicineHumansPhiladelphia ChromosomeMyeloproliferative neoplasmMyeloproliferative Disordersbusiness.industryCase-control studyCancerfood and beveragesMyeloproliferative neoplasmssecond cancersarterial eventsNeoplasms Second PrimaryThrombosisCell BiologyHematologyOdds ratioArteriesmedicine.diseasesecond cancersThrombosisSettore MED/15 - MALATTIE DEL SANGUEarterial events030220 oncology & carcinogenesisCase-Control StudiesMultivariate Analysis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSkin cancerbusiness030215 immunologyFollow-Up StudiesBlood
researchProduct

Towards the Point of Care and Noninvasive Classification of Bladder Cancer from Urine Sediment Infrared Spectroscopy. Spectral differentiation of nor…

2021

Abstract Bladder cancer (BC) is the 9th cancer cause of death and one of most cost-intensive in the world. The diagnostic tools are still not at all satisfactory. Herein we evaluated the potential of infrared spectroscopy to detect molecular changes that precede and accompany the carcinogenesis in voided urine sediment. We collected 165 samples from patients being diagnosed for BC and measured them with attenuated total reflectance Fourier transformed infrared spectroscopy (ATR FTIR). Samples were primarily divided into three groups according to cytology that indicated the presence of normal, abnormal and cancer cells. ATR FTIR spectra of sediments were analyzed with the use of partial leas…

medicine.medical_specialtyInfrared spectroscopy02 engineering and technology01 natural sciencesGastroenterologyAnalytical ChemistryInternal medicineCytologyurine sedimentmedicineMedicine and Health Sciencesreflection (ATR)infrared spectroscopySpectroscopyBladder cancerbusiness.industry010401 analytical chemistryCancerHistologyGold standard (test)Point-of-Care analysis021001 nanoscience & nanotechnologymedicine.disease3. Good health0104 chemical sciencesAttenuated total reflectionCancer cellbladder cancer0210 nano-technologybusiness
researchProduct

The estrogen receptor α:insulin receptor substrate 1 complex in breast cancer: structure–function relationships

2007

Background: Insulin receptor substrate 1 (IRS-1) is a signaling molecule that exerts a key role in mediating cross talk between estrogen receptor a (ERa) and insulin-like growth factor 1 (IGF-1) in breast cancer cells. Previously, we demonstrated that a fraction of IRS-1 binds ERa, translocates to the nucleus, and modulates ERa-dependent transcription at estrogen response elements (ERE). Here, we studied structure-function relationships of the ER-a:IRS-1 complex under IGF-1 and/or estradiol (E 2 ) stimulation. Materials and methods: ERa and IRS-1 deletion mutants were used to analyze structural and functional ERα/IRS-1 interactions. IRS-1 binding to ERE and IRS-1 role in ERa-dependent ERE t…

medicine.medical_specialtyInsulin Receptor Substrate ProteinsActive Transport Cell NucleusEstrogen receptorRepressorBreast NeoplasmsBiologyStructure-Activity Relationshipestrogen receptor alpha (ERa) Insulin receptor substrate 1 (IRS-1) breast cancerCell Line TumorInternal medicineCoactivatormedicineHumansInsulin-Like Growth Factor IReceptors InterferonEstradiolEstrogen Receptor alphaHematologyDNA-binding domainPhosphoproteinsPeptide FragmentsReceptor InsulinProtein Structure TertiaryCell biologyIRS1Repressor ProteinsPleckstrin homology domainEndocrinologyOncologyInsulin Receptor Substrate ProteinsFemaleChromatin immunoprecipitationProtein BindingAnnals of Oncology
researchProduct

An Intention-to-Treat Competing-Risk Model for Candidates with Hepatocellular Cancer Awaiting Liver Transplantation

2018

Background: Since the introduction of the Milan Criteria (MC), all systems, which describe post-transplant prognosis of patients with hepatocellular cancer (HCC), are exclusively based on characteristics available at surgery, and neglect the intention-to-treat principles. This study, based on a large international HCC patient cohort, aimed to develop comprehensive intention-to-treat models through a competing-risk analysis. We used data available at first referral to predict the risk of delisting and HCC-related death after liver transplantation (LT).   Methods: Twelve centres in the United States, Europe and Asia created a Derivation Set (n=2,318) and an external Validation Set (n=773) of …

medicine.medical_specialtyIntention-to-treat analysisHepatocellular cancerReferralbusiness.industrymedicine.medical_treatmentMilan criteriaLiver transplantationdigestive system diseasesDonationInternal medicineCohortMedicinebusinessAlpha-fetoproteinSSRN Electronic Journal
researchProduct

The Impact of Narrow-band Imaging on the Pre- and Intra- operative Assessments of Neoplastic and Preneoplastic Laryngeal Lesions. A Systematic Review

2020

Abstract Introduction Narrow-band imaging is an endoscopic diagnostic tool that, focusing on superficial vascular changes, is useful to detect suspicious laryngeal lesions, enabling their complete excision with safe and tailored resection margins. Objectives To analyze the applications and benefits of narrow-band imaging in detecting premalignant and malignant laryngeal lesions through a comparison with white-light endoscopy. Data Synthesis A literature search was performed in the PubMed, Scopus and Web of Science databases using strict keywords. Then, two authors independently analyzed the articles, read the titles and abstracts, and read completely only the relevant studies according to c…

medicine.medical_specialtyIntra operativeLesion03 medical and health sciences0302 clinical medicinePositive predicative valuemedicine030223 otorhinolaryngologyLeukoplakiaNarrow-band imagingmedicine.diagnostic_testbusiness.industryRCancerlarynx cancermedicine.diseaseEndoscopySettore MED/31 - OtorinolaringoiatriaRF1-547OtorhinolaryngologyFeature (computer vision)030220 oncology & carcinogenesisMedicineSystematic ReviewRadiologymedicine.symptombusinessnarrow-band imagingearly diagnosis
researchProduct